ZYCUBO is a subcutaneous injectable formulation of copper histidinate designed to restore copper homeostasis and maintain adequate copper levels in patients with Menkes disease.
A recent study found permanent pacemaker infection (PPMI) in 2.09% patients, with infections more prevalent in devices implanted over 12 months prior. Diabetes and Hypertension were the most common comorbidities.…
New Delhi: The Union Ministry of Health and Family Welfare has appointed two new inspectors under the Drugs and Cosmetics Act, 1940, authorizing them to exercise powers across the entire…
A prospective validation study showed that using a newer, higher D-dimer cutoff can safely rule out leg deep vein thrombosis (DVT) in a larger proportion of patients. This approach reduced…
Breastfeeding may lower mothers’ later life risks of depression and anxiety for up to 10 years after pregnancy, suggest the findings of a small observational study, published in the open…
RFK Jr. is considering changes to the federal vaccine injury compensation program.
Oz downplayed the effects of cuts to Medicaid and defended RFK Jr.'s moves on vaccines.
A new study published in the Journal of American Medical Association showed that Ethosuximide was linked to decreased tolerability and did not outperform a placebo in the treatment of irritable…
Vadodara: In a major boost for cancer treatment and drug stability, researchers have developed a new freeze-dried formulation that can significantly extend the shelf life and post-reconstitution stability of key…
New Delhi: One of the most closely watched controversies in India's pharmaceutical sector last year, surrounding the continuation of the Drugs Controller General of India (DCGI) beyond retirement, has been…